Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
Igor Astsaturov(Fox Chase Cancer Center), Erica A. Golemis(Fox Chase Cancer Center), Catherine G.N. Sharma(Fox Chase Cancer Center), Margret B. Einarson(Fox Chase Cancer Center), Natalya Skobeleva(Fox Chase Cancer Center), Karthik Devarajan(Fox Chase Cancer Center), Louis M. Weiner(Georgetown University), Vladimir Ratushny(University of Pennsylvania), Tetyana Bagnyukova(Fox Chase Cancer Center), Nadezhda Tikhmyanova(Fox Chase Cancer Center), Anna Pecherskaya(Fox Chase Cancer Center), Sandra A. Jablonski(Georgetown University), Anna L. Sukhanova(Fox Chase Cancer Center), Joshua S. Silverman(NYU Langone Health), Rochelle E. Nasto(Fox Chase Cancer Center), Yan Zhou(University of California, San Francisco), Ilya G. Serebriiskii(Fox Chase Cancer Center)
Cited by 144
Related Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Monoclonal Antibodies in Cancer Therapy
|Antibodies|2020|799
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
|Journal of Clinical Investigation|2012|538
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
|Nature Biotechnology|2005|238